nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
|
Gumusay, Ozge |
|
|
203 |
2 |
p. 197-204 |
artikel |
2 |
Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
|
Carbajal-Ochoa, Walter |
|
|
203 |
2 |
p. 257-269 |
artikel |
3 |
Breast cancer outcomes based on method of detection in community-based breast cancer registry
|
Bennett, Debbie Lee |
|
|
203 |
2 |
p. 215-224 |
artikel |
4 |
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer
|
Iwamoto, Takayuki |
|
|
203 |
2 |
p. 225-234 |
artikel |
5 |
Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer
|
Check, Devon K. |
|
|
203 |
2 |
p. 329-338 |
artikel |
6 |
Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
|
Yue, Meng |
|
|
203 |
2 |
p. 373-381 |
artikel |
7 |
Complete elimination of estrogen receptor α by PROTAC estrogen receptor α degrader ERD-148 in breast cancer cells
|
Hu, Biao |
|
|
203 |
2 |
p. 383-396 |
artikel |
8 |
Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey
|
Fairhurst, K. |
|
|
203 |
2 |
p. 187-196 |
artikel |
9 |
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus
|
Sokolenko, Anna P. |
|
|
203 |
2 |
p. 307-315 |
artikel |
10 |
Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system
|
Shim, Veronica C. |
|
|
203 |
2 |
p. 281-289 |
artikel |
11 |
Hereditary cancer testing in a diverse sample across three breast imaging centers
|
Westbrook, Laura |
|
|
203 |
2 |
p. 365-372 |
artikel |
12 |
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial
|
Rogers, Christine |
|
|
203 |
2 |
p. 317-328 |
artikel |
13 |
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
|
Gu, Stephanie |
|
|
203 |
2 |
p. 271-280 |
artikel |
14 |
Quantitative assessment of breast volume changes after whole-breast irradiation for breast cancer using breast auto-segmentation
|
Lee, Tae Hoon |
|
|
203 |
2 |
p. 205-214 |
artikel |
15 |
Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations
|
Shah, Shivani A. |
|
|
203 |
2 |
p. 397-406 |
artikel |
16 |
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium
|
Brandão, Mariana |
|
|
203 |
2 |
p. 351-363 |
artikel |
17 |
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB)
|
Rothschild, Harriet T |
|
|
203 |
2 |
p. 245-256 |
artikel |
18 |
The largest genome-wide association study for breast cancer in Taiwanese Han population
|
Hsu, Yu-Ching |
|
|
203 |
2 |
p. 291-306 |
artikel |
19 |
The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry
|
Lammers, Senna W. M. |
|
|
203 |
2 |
p. 339-349 |
artikel |
20 |
Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study
|
Schiza, Aglaia |
|
|
203 |
2 |
p. 235-243 |
artikel |